Cancer/testis antigens FBXO39 and CEP55 expression correlates with survival in GBM patients. Azimi P, Bazrgar M, Yazdanian T, Totonchi M, et al. PLoS One 2025;20:e0326054.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Azimi P, Bazrgar M, Yazdanian T, Totonchi M, et al. Cancer/testis antigens FBXO39 and CEP55 expression correlates with survival in GBM patients. PLoS One 2025;20:e0326054.
PMID: 40504854